Evidence map›Paper›PMID 36285177›Full record

ReviewOpen forum infectious diseases2022

Aurélie Baldolli, Richard Chocron, Sylvie Dargère, Jocelyn Michon, Claire Daurel, Angélique Thuillier-Lecouf, Renaud Verdon

Open access · goldAbstract readReview
In one paragraph

Review in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Journal of human immunity · 2026
    Article
  2. Article
  3. DisseminatedInfection and drug resistance · 2026
    Article
  4. Journal of clinical imaging science · 2026
    Article
  5. Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  6. JAAD case reports · 2025
    Article
  7. The Brief Case: Complexity of laboratory diagnosis ofJournal of clinical microbiology · 2025
    Review
  8. Disseminated Infection WithCase reports in infectious diseases · 2025
    Article
  9. Clinical case reports · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. DisseminatedMicroorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Aurélie BaldolliCHU de Caen, Infectious Diseases Department, Avenue de la Côte de Nacre, Caen, F-14000, France.
Richard ChocronEmergency department, European Georges Pompidou Hospital (AP-HP), 75015, Paris, France.
Sylvie DargèreCHU de Caen, Infectious Diseases Department, Avenue de la Côte de Nacre, Caen, F-14000, France.
Jocelyn MichonCHU de Caen, Infectious Diseases Department, Avenue de la Côte de Nacre, Caen, F-14000, France.
Claire DaurelCHU de Caen, Microbiology Department , Avenue de la Côte de Nacre, Caen, F-14000, France.
Angélique Thuillier-LecoufCHU de Caen, Nephrology Department , Avenue de la Côte de Nacre, Caen, F-14000, France.
Renaud VerdonCHU de Caen, Infectious Diseases Department, Avenue de la Côte de Nacre, Caen, F-14000, France.
Centre Hospitalier Universitaire de Caen Normandie · FRAssistance Publique – Hôpitaux de Paris · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We describe 2 cases of Results: Fifty-two cases are reported. Predisposing factors were receipt of SOT (40.4%) and autoimmune disease (36.5%). Infection was disseminated in 86.5% of cases. Organs involved were lymph nodes (72.3%), gastrointestinal tract (56.5%), lung (35.5%), and bone marrow (28.8%). Most patients were treated with at least 3 antimycobacterial agents (98%), with a clinical cure achieved in 54.9%. In multivariate analysis, lack for cure was associated with age of the time infection (odds ratio [OR], 15.81 [95% confidence interval {CI}, 2.92-152.93]; Conclusions:

Indexed as

HIV uninfectedimmunocompromisedMycobacterium genavensesolid organ transplant

Identifiers

PMID36285177
PMCPMC9585469
OpenAlexW4298124574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.